Individuals Coming Off Slimming Jabs Put On Pounds Far More Rapidly Than Those on Conventional Diets

Fresh analysis reveals that people who discontinue blockbuster GLP-1 drugs like Wegovy and Mounjaro tend to recover shed pounds at a significantly accelerated pace than those who end traditional diet and exercise programs.

Published data in a major health publication points out that while overweight individuals often shed substantial amounts of their body weight while undergoing treatment, the mass is regained at an estimated rate of nearly a kilo each month upon discontinuation.

"Users using these medications should be aware of the danger of rapid rebound weight gain when the treatment ends," stated researcher Dr. Susan Jebb.

Such speed of recovery means a reversion to original weight in about 18 months.

Analyzing Approaches

The analysis, which examined 37 of trials involving over 9,000 of patients, compared the results of these new drugs with other pills.

Researchers emphasize that people who lose weight through dieting generally have a more gradual weight regain—around 100 grams monthly—once they finish.

The Reason for the Fast Rebound

Nutrition scientists believe the mechanism of the injections explains the heightened rebound.

These medications imitate a natural hormone called GLP-1, which helps regulate hunger.

"Long-term administration of the hormone levels far above than the body's typical production could lead to the body to produce less of its endogenous hormone, and may also lessen responsiveness to its effects," noted Dr. Adam Collins, a dietetics researcher.

"Withdrawal of this medication means appetite is uncontrolled, making excessive eating a significant risk."

A Chronic Issue?

Health authorities advise the jabs for people with obesity-related health risks, accompanied by recommended diet and exercise modifications.

Professionals say that, considering the likelihood of weight regain, the therapy should be considered life-long.

This opinion is reinforced by drug manufacturers, who say that the findings "underscore the persistent character of obesity," similar to managing conditions like high blood pressure.

User Accounts

Users who have discontinued the medication explain a powerful return of hunger.

"I experienced a trigger flipping and you're instantly ravenous," said one woman.

This challenge is worsened if individuals have not developed sustainable dietary or behavioural changes during treatment.

Widespread Interest

Survey data suggest that a significant number of people in the UK have tried these injections in the last 12 months, with demand remaining high.

• Use is higher among females than men.
• The middle-aged demographic shows the highest usage rates.
• Many obtain the medications through private prescriptions rather than the NHS.

In conclusion, experts emphasize that while GLP-1 drugs are powerful agents for weight loss, they are not a magic cure and lasting health benefits likely depends on integrated lifestyle changes.